cardiovascular outcomes

SELECT trial data, MACE endpoints, and the cardioprotective evidence.

beyond glycemic control

This unit covers the landmark SELECT trial that demonstrated a 20% reduction in major adverse cardiovascular events, the proposed mechanisms linking GLP-1 receptor agonism to cardiovascular protection, and the clinical implications for patients with established atherosclerotic disease.

Interactive Trial Data

Explore SELECT trial MACE outcomes and event curves.

SELECT trial MACE reduction chart

Knowledge Check

Test your understanding of cardiovascular trial design and outcomes.

Practice

Apply cardiovascular outcome concepts before moving to diabetes management.